Top Markets
#1 Black Phoenix Black Phoenix +828.29%
#2 Not in Employment, Education, or Training Not in Employment, Education, or Training +27.18%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.50%
#4 pipedog pipedog +22.01%
#5 Bless Bless +21.83%
#6 SAFEcoin SAFEcoin +20.57%
#7 Magma Finance Magma Finance +20.19%
#8 Beam Beam +19.74%
#9 PondCoin PondCoin +18.75%
#10 YFSX YFSX +15.99%
Coin of the day
Black Phoenix Black Phoenix
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
Voronoi, Inc. Voronoi, Inc.

Voronoi, Inc.

310210
Hisse Senetlerindeki Sıralama #6293
Voronoi, Inc., founded in 2015 and based in Incheon, South Korea, is a... Voronoi, Inc., founded in 2015 and based in Incheon, South Korea, is a biotechnology company dedicated to the research, development, and identification of small molecule kinase inhibitors. Its extensive product pipeline addresses various medical needs. Key candidates include VRN01, an oral leucine-rich repeat kinase 2 (LRRK2) inhibitor, being developed for glioblastoma multiforme, brain cancer, and pancreatic cancer. Treatments for lung cancer are represented by VRN07, VRN06, and VRN11, while VRN08 and VRN10 are in development for breast cancer. Additionally, VRN02 targets rheumatoid arthritis and atopic dermatitis. The company's pipeline further encompasses VRN04-1 for autoimmune conditions, VRN04-2 for multiple sclerosis and amyotrophic lateral sclerosis (ALS), VRN13 for pulmonary arterial hypertension, and VRN14 for challenging solid tumors.
Hisse Fiyatı
$115.48
Piyasa Değeri
$2.12B
Değişim (1 gün)
0.72%
Değişim (1 yıl)
29.38%
Ülke
KR
Ticaret Voronoi, Inc. (310210)

Kategori

Healthcare
Voronoi, Inc. (310210) için kazanç
2026 itibarıyla kazanç TTM: 0
Voronoi, Inc. şirketinin en son finansal raporlarına göre, mevcut kazancı 0'dir. 2026 yılında şirket 0 kazanç elde etti, bu 2026 yılındaki 0 kazanca göre önceki yıla eşit. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
Voronoi, Inc. için kazanç geçmişi 2026 - 2026
Her yılın sonundaki kazanç
Yıl Kazanç Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakipler için kazanç
Şirket Kazanç Kazanç Farkı Ülke
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH